Effects of a Very Low Carbohydrate Diet on Symptoms of Irritable Bowel Syndrome (IBS)
NCT ID: NCT00616200
Last Updated: 2017-10-16
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
17 participants
INTERVENTIONAL
2009-08-31
2010-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
Very low carbohydrate diet
4 weeks on strictly controlled low carbohydrate diet
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Very low carbohydrate diet
4 weeks on strictly controlled low carbohydrate diet
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Meet Rome II Criteria for IBS-D
3. Body mass index \> 25 kg/m\^2
4. Desire to use a very low carbohydrate diet for weight loss
5. Score of \> 36 on the FBDSI
6. Ability to understand consent form
7. In stable health by screening history, physical examination performed by a study physician, laboratory tests (normal blood counts, kidney function tests, liver tests, TSH).
Exclusion Criteria
2. History of inflammatory bowel disease
3. History of any gastrointestinal surgery that preceded the onset of IBS symptoms
4. Pregnancy or breastfeeding
5. FBDSI symptom score of ≤ 36
6. Inability to understand consent form
7. Diabetes requiring medications (must be controlled with diet and exercise alone).
8. Chronic narcotic use for any reason
9. Use of serotonin-selective reuptake inhibitors unless patient has been on a stable dose for at least 4 weeks.
10. Use of any over-the-counter or prescription weight loss medications.
11. Any chronic or unstable diseases (e.g., kidney disease, heart disease, or cancer) that may put the subject at increased risk from the intervention
12. Any of the following baseline abnormalities of laboratory tests or physical exam findings:
1. Serum creatinine \> 1.5 mg/dL in men, \> 1.3 mg/dL in women.
2. Liver disease (AST or ALT \> 2 times the upper limit of normal or total bilirubin \> 1.6mg/dL).
3. Blood pressure \> 160/100 mm Hg.
4. Fasting triglycerides \> 600 mg/dL.
5. Fasting serum low-density lipoprotein (LDL) cholesterol \> 190 mg/dL.
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of North Carolina, Chapel Hill
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Douglas Drossman, MD
Role: PRINCIPAL_INVESTIGATOR
UNC Chapel Hill
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UNC Center for Functional GI & Motility Disorders
Chapel Hill, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Austin GL, Dalton CB, Hu Y, Morris CB, Hankins J, Weinland SR, Westman EC, Yancy WS Jr, Drossman DA. A very low-carbohydrate diet improves symptoms and quality of life in diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol. 2009 Jun;7(6):706-708.e1. doi: 10.1016/j.cgh.2009.02.023. Epub 2009 Mar 10.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GCRC 2392
Identifier Type: -
Identifier Source: secondary_id
05-2899
Identifier Type: -
Identifier Source: org_study_id